Use of Alpelisib for Patients with PIK3CA-mutated advanced Breast Cancer

被引：0
|
作者：
Malter, Wolfram [1 ]
Alakus, Hakan [2 ]
Mallmann, Peter [1 ]
Bruns, Christiane [2 ]
机构：
[1] Univ Cologne, Uniklin Koln, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Cologne, Germany
[2] Univ Cologne, Uniklin Koln AoR, Klin & Poliklin Allgemein Viszeral & Tumorchirurg, Kerpener Str 62, D-50937 Cologne, Germany
来源：
ONKOLOGE | 2019年 / 25卷 / 08期
关键词：
D O I：
10.1007/s00761-019-0619-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：724 / 725
页数：2
相关论文
共 50 条
  • [21] Alpelisib Plus Fulvestrant or Letrozole Demonstrates Sustained Benefits Across Subgroups of Patients with PIK3CA-Mutated HR+/HER2-Advanced Breast Cancer
    Jacobson, Anne
    [J]. ONCOLOGIST, 2022, 27 : S13 - S14
  • [22] FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
    Narayan, Preeti
    Prowell, Tatiana M.
    Gao, Jennifer J.
    Fernandes, Laura L.
    Li, Emily
    Jiang, Xiling
    Qiu, Junshan
    Fan, Jianghong
    Song, Pengfei
    Yu, Jingyu
    Zhang, Xinyuan
    King-Kallimanis, Bellinda L.
    Chen, Wei
    Ricks, Tiffany K.
    Gong, Yutao
    Wang, Xing
    Windsor, Katherine
    Rhieu, Steve Y.
    Geiser, Gerlie
    Banerjee, Anamitro
    Chen, Xiaohong
    Turcu, Francisca Reyes
    Chatterjee, Deb K.
    Pathak, Anand
    Seidman, Jeffrey
    Ghosh, Soma
    Philip, Reena
    Goldberg, Kirsten B.
    Kluetz, Paul G.
    Tang, Shenghui
    Amiri-Kordestani, Laleh
    Theoret, Marc R.
    Pazdur, Richard
    Beaver, Julia A.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (07) : 1842 - 1849
  • [23] Alpelisib for the treatment of PIK3CA-mutated, hormone receptor-positive, HER2-negative metastatic breast cancer
    Leenhardt, Fanny
    Alexandre, Marie
    Jacot, William
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (06) : 667 - 675
  • [24] Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
    Yeom, Jiah
    Cho, Yoonju
    Ahn, Seoungyob
    Jeung, Soyoung
    [J]. FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [25] In vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines
    Maeda, Marika
    Ochiai, Kazuhiko
    Michishita, Masaki
    Morimatsu, Masami
    Sakai, Hiroki
    Kinoshita, Nayuta
    Sakaue, Motoharu
    Onozawa, Eri
    Azakami, Daigo
    Yamamoto, Masami
    Ishioka, Katsumi
    Sadahira, Takuya
    Watanabe, Masami
    Tanaka, Yoshikazu
    [J]. ONCOLOGY REPORTS, 2022, 47 (04)
  • [26] Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
    Roufai, D. Bello
    Goncalves, A.
    Rouge, T. De La Motte
    Akla, S.
    Blonz, C.
    Grenier, J.
    Gligorov, J.
    Saghatchian, M.
    Bailleux, C.
    Simon, H.
    Desmoulins, I
    Tharin, Z.
    Renaud, E.
    Bertho, M.
    Benderra, M-A
    Delaloge, S.
    Robert, L.
    Cottu, P.
    Pierga, J. Y.
    Loirat, D.
    Bertucci, A.
    Renouf, B.
    Bidard, F. C.
    Lerebours, F.
    [J]. ONCOGENE, 2023, 42 (23) : 1951 - 1956
  • [27] Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program
    D. Bello Roufai
    A. Gonçalves
    T. De La Motte Rouge
    S. Akla
    C. Blonz
    J. Grenier
    J. Gligorov
    M. Saghatchian
    C. Bailleux
    H. Simon
    I. Desmoulins
    Z. Tharin
    E. Renaud
    M. Bertho
    M-A Benderra
    S. Delaloge
    L. Robert
    P. Cottu
    J. Y. Pierga
    D. Loirat
    A. Bertucci
    B. Renouf
    F. C. Bidard
    F. Lerebours
    [J]. Oncogene, 2023, 42 : 1951 - 1956
  • [28] A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer
    Jhaveri, Komal
    Drago, Joshua Z.
    Shah, Payal Deepak
    Wang, Rui
    Pareja, Fresia
    Ratzon, Fanni
    Iasonos, Alexia
    Patil, Sujata
    Rosen, Neal
    Fornier, Monica N.
    Sklarin, Nancy T.
    Chandarlapaty, Sarat
    Modi, Shanu
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (14) : 3867 - 3875
  • [29] Regular aspirin (ASA) use and survival in patients with PIK3CA-mutated metastatic colorectal cancer (CRC)
    Kothari, Nishi
    Kim, Richard D.
    Gibbs, Peter
    Yeatman, Timothy Joseph
    Schell, Michael J.
    Desai, Jayesh
    Tie, Jeanne
    Lipton, Lara Rachel
    Jorissen, Robert N.
    Wong, Hui-Li
    Sieber, Oliver
    Day, Fiona
    Faragher, Ian
    Jones, Ian
    Ben Tran
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [30] SEQUence of Endocrine therapy in advanced Luminal Breast cancer (SEQUEL-Breast): A phase 2 study on fulvestrant beyond progression in combination with alpelisib for PIK3CA-mutated, HR+HER2-advanced breast cancer
    Almekinders, Cornelia Am
    Konings, Inge Rhm
    van der Noort, Vincent
    van den Berg, Susan M.
    Bos, Monique Emm
    Dezentje, Vincent O.
    [J]. CANCER RESEARCH, 2023, 83 (05)
12345